Iofina achieved record first quarter production thanks to the new IO#7 plant and iodine prices are rising.
The iodine producer was hampered by poor weather but still increased the production by 10% to 134.4MT. The first half production target has been reduced to 310MT-330MT due to lower plant efficiencies and planned works.
Although full year production targets have been trimmed from 621MT to 598MT, the higher iodine price means that the 2019 pre-tax profit forecast is edged up from $1.04m to $1.1m.
© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Omega Diagnostics will lose money this year, but it is on course to become profitable in 2020-21 as sales of the VISITECT CD4 test.
House broker Shore Capital has slashed its pre-tax profit forecast for engineer Tricorn Group by two-thirds to £420,000.
Evgen Pharma has entered into an agreement with The University of Dundee for the use of SFX-01 in a clinical trial in non-alcoholic steatohepatitis and liver fibrosis, where there is no existing treatment.